#03 Carolina Oliveira, the founder & CEO of OneSkin Technologies | Skin Aging, OneSkin, and Building a Longevity Company
Live Longer World
00:00
Are You Seeing Results in Humans?
We've done a 12 weeks clinical study to evaluate both like improvement in the appearance, fine lines, firmness, elasticity and skin barrier. And what are we found that was very interesting that the side of the peptide showed 15 to 18% improvement in the skin barrier. So again, it's showing that when you target like a specific mechanism in the end, you're improving the function of the skin. We also have another study ongoing now where we have subjects. But sorry, I forgot your question.
Transcript
Play full episode
